PRCSG_network

Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient‐Reported Outcomes in a Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Withdrawal Trial - Brunner - 2026 - Arthritis & Rheumatology - Wiley Online Library acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar…

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial - Brunner - Arthritis Care & Research - Wiley Online Library acrjournals.onlinelibrary.wiley.com/doi/10.1002/ac…

🎄 Lace up & save! The Jingle Bell Run is coming, and now’s your chance to join in for less. Use code FALL for $5 off registration — limited time only! 🏃‍♀️❄️ Run for fun. Run for a cause. 👉 arthr.org/4lT6Cy2 #JingleBellRun

"Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting" — Read it on @ResearchGate: researchgate.net/publication/39…

25 Years of Biologics for the Treatment of Pediatric Rheumatic Disease: Advances in Prognosis and Ongoing Challenges - Shishov - 2025 - Arthritis Care & Research - Wiley Online Library acrjournals.onlinelibrary.wiley.com/doi/10.1002/ac…

Clinically Inactive Disease and Remission in Patients with Juvenile Idiopathic Arthritis Receiving Tofacitinib: Pos… pubmed.ncbi.nlm.nih.gov/40312101/

Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations… pubmed.ncbi.nlm.nih.gov/39955164/

Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular-Course Juvenile Idiopathic Ar… pubmed.ncbi.nlm.nih.gov/39135452/

Efficacy and Safety of Tofacitinib in Patients with Active Systemic Juvenile Idiopathic Arthritis acrabstracts.org/abstract/effic…

Pharmacokinetics of Ustekinumab in Patients with Juvenile Psoriatic Arthritis in a Real‑World Opportunistic Study acrabstracts.org/abstract/pharm…

Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients with Polyarticular‐Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open‐label, Phase 1 Trial - Brunner - Arthritis Care & Research - Wiley Online Library acrjournals.onlinelibrary.wiley.com/doi/10.1002/ac…

Transcriptional Profiling of Tofacitinib Treatment in Juvenile Idiopathic Arthritis: Implications for Treatment Response Prediction - Eloseily - Arthritis Care & Research - Wiley Online Library acrjournals.onlinelibrary.wiley.com/doi/10.1002/ac…

Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study jrheum.org/content/51/11/…

S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthrit… pubmed.ncbi.nlm.nih.gov/38918871/

Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary re… pubmed.ncbi.nlm.nih.gov/38849152/

We invite you to join us for a late breaking poster presentation on Safety and Efficacy of tofacitinib with sJIA @ACRheum on November 18. Poster L09: November 18, 2024, 10:30 AM – 12:30 PM, Poster Session C, (L01-L14) Late Breaking Posters

We invite you to join us for a poster presentation on PK of ustekinumab in Juvenile Psoriatic Arthritis @ACRheum on November 16. Poster 0384: November 16, 2024, 10:30 AM – 12:30 PM, Poster Session A, Pediatric Rheumatology – Clinical Poster I

Dr. Ekemini Ogbu Named Chair of ACR Pediatric Rheumatology Committee oaacd.wordpress.com/2024/08/28/dr-…

Intravenous Golimumab in Children with Polyarticular-Course Juvenile Idiopathic Arthritis: Long-term Extension of an Open-label, Phase 3 Study jrheum.org/content/early/…